Previous 10 | Next 10 |
NEW YORK and VANCOUVER, British Columbia and LOS ANGELES, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“ BriaCell ” or the “ Company ”), a clinical-stage biotechnology company specializing in targeted im...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re halfway through the week but still going strong with a peek at the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com But hold on just a second. ...
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virt...
BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX-V:BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. BriaCell achieved positive proof-of-concept in a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast...
BriaCell Therapeutics (BCTX) announces the open recruitment and enrollment of their collaborative clinical study with Incyte (INCY).The Phase I/IIa combination study is designed to evaluate BriaCell’s lead candidate, Bria-IMT, with Incyte’s checkpoint inhibitor, retifanlimab, an...
NEW YORK and VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies for advan...
BERKELEY, Calif. and VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies f...
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13 th - 15 th , 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meeti...
Gainers: Osmotica Pharmaceuticals (OSMT) +38%, Star Equity (STRR) +16%, Atossa Therapeutics (ATOS) +15%, Vor Biopharma (VOR) +12%, Rezolute (RZLT) +10%.Losers: Theravance Biopharma (TBPH) -8%, Corbus Pharmaceuticals (CRBP) -8%, Kaleido Bi...
Gainers: Midatech Pharma (MTP) +37%, Cellect Biotechnology (APOP) +30%, Synaptogenix (SNPX) +24%, Clearside Biomedical (CLSD) +16%, Tiziana Life Sciences (TLSA) +16%.Losers: CureVac (CVAC) -44%, Novan (NOVN) -19%, Prothena (PRTA) -14...
News, Short Squeeze, Breakout and More Instantly...
BriaCell Therapeutics Corp. Company Name:
BCTX Stock Symbol:
NASDAQ Market:
BriaCell Therapeutics Corp. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...
Progression free survival (PFS) extended to 9.1 months in ADC resistant patient - quadruple the PFS of patients in similar studies 1, 2, 3 Significant reduction of “Eye-Bulging” metastatic breast cancer tumor was previously rep...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...